This study revealed that the CISD1 expression was higher in breast cancer, cholangiocarcinoma, colon cancer, esophageal cancer, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung cancer, gastric cancer, and endometrial adenocarcinoma compared to the normal tissues. Here, CISD1 is linked to cholangiocarcinoma.